Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
1789
-
Total 13F shares, excl. options
-
1.25B
-
Shares change
-
+1.65M
-
Total reported value, excl. options
-
$76.5B
-
Value change
-
+$96.5M
-
Put/Call ratio
-
0.65
-
Number of buys
-
681
-
Number of sells
-
-850
-
Price
-
$60.99
Significant Holders of ABBOTT LABORATORIES - COM (ABT) as of Q2 2018
1,919 filings reported holding ABT - ABBOTT LABORATORIES - COM as of Q2 2018.
ABBOTT LABORATORIES - COM (ABT) has 1,789 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.25B shares
.
Largest 10 shareholders include VANGUARD GROUP INC (137M shares), Capital Research Global Investors (131M shares), BlackRock Inc. (116M shares), STATE STREET CORP (67.2M shares), WELLINGTON MANAGEMENT GROUP LLP (41.7M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (39.1M shares), NORTHERN TRUST CORP (26.1M shares), MORGAN STANLEY (21.2M shares), WELLS FARGO & COMPANY/MN (20.3M shares), and GEODE CAPITAL MANAGEMENT, LLC (20M shares).
This table shows the top 1789 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.